Prolonged plasma levels of ketoprofen after oral administration of its α-cyclodextrin conjugate/ethylcellulose dispersion in rats

Journal of Inclusion Phenomena

Volumn 44, Issue 1-4, 2002, Pages 159-161

  Hirayama, Fumitoshi ^a   Kamada, Makoto ^a   Yano, Hideki ^a   Udo, Koichi ^a   Arima, Hidetoshi ^a   Uekama, Kaneto ^a  

^a Tohoku University   (Japan)

Author keywords

Anti inflammatory effect; Colon specific delivery; Cyclodextrin conjugate; Delayed release; Ketoprofen; Sustained release

Indexed keywords

ALPHA CYCLODEXTRIN; ANTIINFLAMMATORY AGENT; ETHYL CELLULOSE; HYDROXYL GROUP; KETOPROFEN;

CONFERENCE PAPER; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DISPERSION; DRUG BLOOD LEVEL; DRUG CONJUGATION; DRUG DESIGN; DRUG EFFECT; MALE; MAXIMUM ALLOWABLE CONCENTRATION; NONHUMAN; PAW EDEMA; RAT;

EID: 0347656901     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023094629718     Document Type: Article

References (8)

1. R.L. Juliano (ed.): Drug Delivery Systems, Oxford University Press, New York (1980).
2. M. Hashida (ed.): Formulation Design of Oral Dosage Forms (in Japanese), Yakugyo-Jihosha, Tokyo (1998).
3. F. Hirayama, K. Minami, and K. Uekama: J. Pharm. Pharmacol. 48, 27 (1996).
4. K. Uekama, K. Minami, and F. Hirayama: J. Med. Chem. 40, 2755 (1997).
5. K. Minami, F. Hirayama, and K. Uekama: J. Pharm. Sci. 87, 715 (1998).
6. H. Yano, F. Hirayama, H. Arima, and K. Uekama: J. Pharm. Sci. 90, 493 (2001).
7. H. Yano, F. Hirayama, H. Arima, and K. Uekama: J. Pharm. Sci. 90, 2103 (2001).
8. H. Yano, F. Hirayama, M. Kamada, H. Arima, and K. Uekama: J. Control. Rel. 79, 102 (2002).